Latest Biogen Idec Stories
CARLSBAD, Calif., April 30, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
RnRMarketResearch.com adds “Optic Neuritis – Pipeline Review, H1 2015” to its store.
RICHMOND, Calif., April 22, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
Natalizumab Was Well-Tolerated Under Double the Standard Dose Schedule NEW YORK, April 20, 2015 /PRNewswire-USNewswire/ -- Extending the dose of an infusion medication for multiple
DUBLIN, April 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7jbhnz/global) has announced the addition of the "Global Haemophilia
WASHINGTON, April 14, 2015 /PRNewswire-USNewswire/ -- A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves
Biogen Expansion Pushes BioMed Realty's 301 Binney Property to 100 Percent Occupied CAMBRIDGE, Mass., April 2, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc.
- Experienced leader and expert clinician to deliver strong outcomes for patients in the areas of Neurology and Immunology ROCKLAND, Mass., April 1, 2015 /PRNewswire/ -- EMD
- Emitting flashes of light; glittering.